Home › Funds › ADAMS STREET PARTNERS LLC › CRVS

ADAMS STREET PARTNERS LLC position in CRVS

CORVUS PHARMACEUTICALS I · Health Care

ADAMS STREET PARTNERS LLC reported holding 3,275,616 shares of CRVS (CORVUS PHARMACEUTICALS I) in its Q2 2026 13F filing — a position valued at US$48.9M, representing 11.06% of its reported portfolio and ranking #4 among its reported holdings. ADAMS STREET PARTNERS LLC has disclosed CRVS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)3.28M sh
Reported value held$48.94M
Portfolio Weight11.06%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ADAMS STREET PARTNERS LLC's CRVS position evolved

ADAMS STREET PARTNERS LLC first disclosed a stake in CRVS in Q3 2023 at 3,275,616 shares (US$4.8M). The position peaked in Q2 2026 at 3,275,616 shares, worth US$48.9M. Across 12 filings, ADAMS STREET PARTNERS LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 3,275,616 shares valued at US$48.9M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.28M $4.78M New
Q4 2023 3.28M $5.77M Hold
Q1 2024 3.28M $5.83M Hold
Q2 2024 3.28M $5.96M Hold
Q3 2024 3.28M $17.30M Hold
Q4 2024 3.28M $17.52M Hold
Q1 2025 3.28M $10.42M Hold
Q2 2025 3.28M $13.10M Hold
Q3 2025 3.28M $24.14M Hold
Q4 2025 3.28M $25.22M Hold
Q1 2026 3.28M $47.92M Hold
Q2 2026 3.28M $48.94M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CRVS and 13F data

CRVS (CORVUS PHARMACEUTICALS I) is a Health Care company. 72 other funds we track also report a position in CRVS — the largest reported positions include ORBIMED ADVISORS LLC (US$107.0M), Vivo Capital, LLC (US$41.9M), PERCEPTIVE ADVISORS LLC (US$39.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRVS

All CRVS fund holders →

FAQ

How long has ADAMS STREET PARTNERS LLC held CRVS?

ADAMS STREET PARTNERS LLC has disclosed CRVS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is ADAMS STREET PARTNERS LLC's current position in CRVS?

As of Q2 2026, ADAMS STREET PARTNERS LLC holds 3.28M shares of CRVS (CORVUS PHARMACEUTICALS I), valued at $48.94M, representing 11.06% of its reported portfolio and ranking #4.

Has ADAMS STREET PARTNERS LLC been buying or selling CRVS?

In the latest 13F filing (Q2 2026), ADAMS STREET PARTNERS LLC held unchanged its position in CRVS. The position peaked in Q2 2026 at 3.28M shares.

Which other funds hold CRVS?

Other major institutional holders of CRVS include ORBIMED ADVISORS LLC, Vivo Capital, LLC, PERCEPTIVE ADVISORS LLC, among 72 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.